Christine Desmedt

36PUBLICATIONS
283CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMolecular targetsCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 17, 2026
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

|Mar 04, 2026
Targeting the Lipid Metabolism Proteins FASN and GPAM in Alveolar Type II Cells Decreases Lung Metastasis.

Xiao-Zheng Liu, Yulia Panina, Weigang Cai

|Dec 25, 2025
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Kristien Borremans, Anirudh Pabba, Gitte Zels

|Dec 02, 2025
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer.

François Richard, Marion Maetens, Karen Van Baelen

|Oct 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State.

Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba

Pageof 6

Frequent Collaborators

18 joint publications

Giuseppe Floris

17 joint publications

François Richard

10 joint publications

Hans Wildiers

8 joint publications

Ha-Linh Nguyen